Analyst firms · Raymond James · ARGX
Raymond James ARGX price target and rating history
argenx SE (ARGX) · Health Care
Raymond James rates argenx SE (ARGX) Strong Buy with a $605 price target, as of its latest action on Oct 10, 2024. It has published 3 rating actions on ARGX since October 2021, including 1 upgrade and 0 downgrades. Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185.
- Current rating
- Strong Buy
- Price target
- $605
- Median target, all firms
- $1,185
- Actions on ARGX
- 3
Raymond James price target on ARGX
Every Raymond James rating on ARGX
- Oct 10, 2024
- Dec 20, 2021
- Oct 28, 2021
How other firms rate ARGX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $1,400 | Aug 26, 2026 |
| Deutsche Bank | Hold | Aug 24, 2026 | |
| Guggenheim | Buy | $1,185 | Aug 4, 2026 |
| Robert W. Baird | Neutral | $858 | Dec 18, 2025 |
| Wolfe Research | Peer Perform | Nov 24, 2025 |
Questions about Raymond James and ARGX
- What is Raymond James's price target for ARGX?
- Raymond James's latest stated price target for argenx SE (ARGX) is $605, from its action on Oct 10, 2024.
- What is Raymond James's rating on ARGX?
- Raymond James rates ARGX Strong Buy, a bullish rating, as of Oct 10, 2024.
- When did Raymond James last change its view on ARGX?
- On Oct 10, 2024, Raymond James resumes coverage at Strong Buy, price target $605.
- How does Raymond James's ARGX target compare with other analysts?
- Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185.
More ARGX rating histories
All Raymond James ratingsARGX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.